PARIS:Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic.
The announcement on Friday, which highlighted the challenges of developing shots at record speed, hinders efforts to develop the multiple options that experts say the world needs to counter a disease that has killed over 1.5 million people.
The news, which came on the same day as Australia axed a domestic vaccine project, is also a blow for many governments that have booked hundreds of millions of doses of the shot, including the European Union, United States and Britain.
Shares in France's Sanofi were down 2.8% at 0910 GMT while Britain's GSK was up 0.2%.
The two companies said they planned to start another study next February, hoping to come up with a more effective vaccine by the end of 2021.
The setback affects one of the most established technologies in vaccines - used against the human papillomavirus, hepatitis B and pertussis among other pathogens - which aims to introduce lab-made proteins into the body to prod the immune system into developing a targeted defence against the novel coronavirus.
It cements the lead of more novel approaches used by vaccines from the likes of Pfizer-BioNTech and Moderna, which use mRNA genetic technology to trick the body into producing those proteins. Both of those shots were found to be about 95% effective in successful large-scale trials.
Delays and additional trials are not unusual but the Sanofi/GSK announcement highlights the unique set of challenges facing drugmakers in multitasking science, speed and logistics during a pandemic that has crushed global economies.
It also underscores why governments have spread their bets by securing shots from different developers.
Australia, meanwhile, cancelled the production of a COVID-19 vaccine developed by the University of Queensland and using an adjuvant made by biotech firm CSL after trials showed it could interfere with HIV diagnosis.
"Science cannot be all about producing positive results; negative results will and must occur," said Diego Silva, an expert at the University of Sydney School of Public Health.
"Negative results are also as important as success in science, since they, too, form part of the evidence base for future research."
DELAYED TO LATE 2021
Sanofi said Friday's results from Phase I/II trials showed "an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years, but a low immune response in older adults likely due to an insufficient concentration of the antigen".
"With this type of vaccine, the result is not a surprise, we know that more antigen is needed in older patients. But when in Phase I and II, drugmakers test tolerance and one cannot test strong dosages," said Jean-Daniel Lelievre, head of clinic immunology and infectious diseases at Henri-Mondor hospital in Creteil, France.
"I would think Sanofi and GSK will be able to improve their vaccine."
Phase III studies were expected to start this month. However Sanofi said it would instead launch a phase 2b study in February.
"The study will include a proposed comparison with an authorized COVID-19 vaccine," the company said, declining to give further details on this.
"If data are positive, a global Phase III study could start in Q2 2021. Positive results from this study would lead to regulatory submissions in the second half of 2021, hence delaying the vaccine's potential availability from mid-2021 to Q4 2021."
The two companies said they had "updated governments and the European Commission where a contractual commitment to purchase the vaccine has been made".
BRITAIN JUMPS AHEAD
The vaccine uses the same recombinant protein-based technology as one of Sanofi's seasonal influenza vaccines. It will be coupled with an adjuvant, a substance that acts as a booster to the vaccine, made by GSK.
Sanofi and GSK have scaled up manufacturing in order to be ready to produce up to one billion doses of their vaccine in 2021. GSK said a goal to produce 1 billion doses of adjuvants - with some expected to be delivered to other partners - in 2021 remained in place but was under review.
The Phase I/II study tested the safety, tolerability and immune response of the vaccine in 440 healthy adults across 11 investigational sites in the United States..
This week, Britain started deploying the Pfizer-BioNTech vaccine, jumping ahead of the rest of the world in the race.
Canada has also given the green light for the shot, while a panel of outside advisers to the U.S. Food and Drug Administration on Thursday voted to endorse emergency-use authorization.
Britain's AstraZeneca Plc and Oxford University have also reported late-stage data for their COVID-19 shot, which showed it has an average success rate of about 70%.
Sanofi is working on another COVID-19 vaccine candidate with U.S. company Translate Bio which uses mRNA technology. Phase I trials are expected to start this month.
Reuters
Fri Dec 11 2020
![Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-12/81607681654_GSK.jpg)
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS Pic
![Lebih 1,600 premis PKS sertai program SOLVE 4 SME Lebih 1,600 premis PKS sertai program SOLVE 4 SME](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/71723651455_TBSOLVE.jpg)
Lebih 1,600 premis PKS sertai program "SOLVE 4 SME"
JKKP memaklumkan penyertaan itu melebihi sasaran jabatan itu dan telah memberi manfaat kepada 70,824 pekerja PKS.
![PRK Nenggiri: PN ada peluang menang, tapi jangan over-confident - Muhyiddin PRK Nenggiri: PN ada peluang menang, tapi jangan over-confident - Muhyiddin](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-04/51713678198_MuhyiddinYassin.jpg)
PRK Nenggiri: "PN ada peluang menang, tapi jangan over-confident" - Muhyiddin
Muhyiddin optimis dengan kemenangan calon PN, Mohd Rizwadi Ismail sekali gus mempertahankan kerusi DUN Nenggiri.
![Ahli ekonomi yakin pertumbuhan KDNK sekitar 5.8 peratus pada suku kedua 2024 Ahli ekonomi yakin pertumbuhan KDNK sekitar 5.8 peratus pada suku kedua 2024](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-06/81717305735_EkonomiMalaysia.jpg)
Ahli ekonomi yakin pertumbuhan KDNK sekitar 5.8 peratus pada suku kedua 2024
Kalangan ahli ekonomi yakin KDNK Malaysia bagi suku kedua 2024 akan berkembang pada 5.8 peratus berbanding 4.2 peratus pada suku pertama tahun ini.
AWANI Pagi: Berita tumpuan & menarik di astroawani.com [15 Ogos 2024]
Antara fokus AWANI Pagi bersama Nursyazwani Saiful Sham dan Afiezy Azaman
- Mayat lelaki di jambatan Klang dipercayai YouTuber Nidza Afham
- BNM denda Maybank, CIMB kerana gangguan perkhidmatan berpanjangan
- JIWA SME: Inovasi kuih sejuk beku jadi kudapan jemaah tunai umrah
#AWANInews #AWANIpagi
- Mayat lelaki di jambatan Klang dipercayai YouTuber Nidza Afham
- BNM denda Maybank, CIMB kerana gangguan perkhidmatan berpanjangan
- JIWA SME: Inovasi kuih sejuk beku jadi kudapan jemaah tunai umrah
#AWANInews #AWANIpagi
![Cisco akan kurangkan 7 peratus tenaga kerja globalnya Cisco akan kurangkan 7 peratus tenaga kerja globalnya](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/41723681507_Ciscologo.jpg)
Cisco akan kurangkan 7 peratus tenaga kerja globalnya
Langkah mengurangkan kakitangan itu dijangka melibatkan kos pra-cukai sehingga AS$1 bilion.
Jiwa SME: Kuih tradisonal sejuk beku 'diterbangkan' ke Tanah Suci
Inovasi pembuatan makanan sejuk beku, terutama kuih muih tradisional telah berjaya membawa produk itu ke peringkat global, terutama dalam memenuhi citarasa jemaah haji dan umrah rakyat Malaysia di Tanah Suci Mekah dan Madinah.
![Gol sulung Mbappe bantu Real Madrid juarai Piala Super UEFA Gol sulung Mbappe bantu Real Madrid juarai Piala Super UEFA](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/51723679998_KylianMbappe.jpg)
Gol sulung Mbappe bantu Real Madrid juarai Piala Super UEFA
"Ia adalah malam yang hebat. Ia adalah detik yang hebat untuk saya. Dan kami memenangi kejuaraan, yang penting - di Madrid anda perlu sentiasa menang."
![“I love you Am, bahagialah di syurga firdausi” - Aufahanie “I love you Am, bahagialah di syurga firdausi” - Aufahanie](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/51723679258_AufahanieNidzaAfh.jpg)
“I love you Am, bahagialah di syurga firdausi” - Aufahanie
Air mata Aufahanie sudah kering meratapi pemergian abang tercinta, Nidza Afham yang ditemui meninggal dunia selepas dilaporkan hilang.
Konsert jelajah: Taylor Swift teruskan konsert London selepas ancaman keganasan
Taylor Swift akan meneruskan persembahan di London pada Khamis, meneruskan jelajah konsert terbesar dunia di tengah-tengah kebimbangan keselamatan susulan cubaan serangan Daesh memaksa pembatalan tarikh konsert di Vienna, minggu lalu.
Taliban rai ulang tahun ketiga pemerintahan Afghanistan
Kerajaan Taliban semalam meraikan ulang tahun ketiga pemerintahannya di Afghanistan dengan perarakan tentera yang memberi penghormatan kepada bom buatan sendiri yang digunakan ketika peperangan, pesawat pejuang dan perbarisan pasukan keselamatan.
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-03/71709993909_TBBERITAx.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
![Tahap pengurusan rantaian bekalan akan dipertingkat - PM Anwar Tahap pengurusan rantaian bekalan akan dipertingkat - PM Anwar](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/71723553013_TBAnwarIbrahim.jpg)
Tahap pengurusan rantaian bekalan akan dipertingkat - PM Anwar
Mesyuarat MPN Ke-6 Tahun 2024 hari ini bersetuju dengan beberapa langkah bagi meningkatkan tahap pengurusan rantaian bekalan yang kukuh, berdaya tahan dan responsif kepada gangguan.
![Olimpik Paris: Lyles raih gangsa acara 200m lelaki, meskipun positif COVID-19 Olimpik Paris: Lyles raih gangsa acara 200m lelaki, meskipun positif COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/81723164238_NoahLyles.jpg)
Olimpik Paris: Lyles raih gangsa acara 200m lelaki, meskipun positif COVID-19
Lyles terpaksa berpuas hati dengan pingat gangsa dalam acara 200m, dengan emas menjadi milik atlet Botswana, Letsile Tebogo.
![[KOLUMNIS] Bahaya maklumat salah: Ancaman keamanan dan keharmonian di Malaysia [KOLUMNIS] Bahaya maklumat salah: Ancaman keamanan dan keharmonian di Malaysia](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-05/41622415528_fake.jpg)
[KOLUMNIS] Bahaya maklumat salah: Ancaman keamanan dan keharmonian di Malaysia
Maklumat yang salah bukan sahaja ancaman di negara-negara Barat tetapi juga semakin menjadi masalah besar di Malaysia.
![KKM belanja RM137 juta setahun bagi menyelenggara 201 klinik kesihatan KKM belanja RM137 juta setahun bagi menyelenggara 201 klinik kesihatan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71721221006_DzulkeflyAhmad.jpg)
KKM belanja RM137 juta setahun bagi menyelenggara 201 klinik kesihatan
KKM membelanjakan sebanyak RM137 juta setahun bagi menyelenggara 201 buah klinik kesihatan di seluruh negara di bawah PSK dengan kontrak selama 5 tahun bermula tahun 2022.
![Olimpik Paris 2024: Atlet renang Australia tarik diri selepas positif COVID-19 Olimpik Paris 2024: Atlet renang Australia tarik diri selepas positif COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71722334055_LaniPallister.jpg)
Olimpik Paris 2024: Atlet renang Australia tarik diri selepas positif COVID-19
Atlet renang Australia Lani Pallister terpaksa menarik diri dari acara bebas 1,500 meter selepas positif COVID-19, menurut pasukan negara itu pada Selasa.
![Biden kembali ke Rumah Putih selepas beberapa hari pengasingan COVID-19 Biden kembali ke Rumah Putih selepas beberapa hari pengasingan COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-10/71696492107_JoeBiden.jpg)
Biden kembali ke Rumah Putih selepas beberapa hari pengasingan COVID-19
Presiden Amerika Syarikat (AS) Joe Biden tiba semula di Rumah Putih pada Selasa selepas beberapa hari diasingkan akibat COVID-19 dan di tengah-tengah khabar angin mengenai kesihatannya.
![Gantung Parlimen: 2 wakil rakyat dibenar mulakan semakan kehakiman Gantung Parlimen: 2 wakil rakyat dibenar mulakan semakan kehakiman](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/51721817034_MuhyiddinYassin.jpg)
Gantung Parlimen: 2 wakil rakyat dibenar mulakan semakan kehakiman
Mahkamah Persekutuan membenarkan dua wakil rakyat memulakan semakan kehakiman bagi mencabar nasihat Muhyiddin untuk menggantung Parlimen sepanjang tempoh darurat pandemik COVID-19.
![Biden pulih daripada gejala COVID-19, ujian negatif Biden pulih daripada gejala COVID-19, ujian negatif](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71721785411_JoeBidenAirForce.jpg)
Biden pulih daripada gejala COVID-19, ujian negatif
Ujian antigen pantas BINAX adalah negatif, bagaimanapun, beliau akan terus dipantau untuk sebarang penyakit berulang.
![Biden alami gejala COVID-19 ringan, ambil ubat antiviral Biden alami gejala COVID-19 ringan, ambil ubat antiviral](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/71716240052_TBJoeBiden.jpg)
Biden alami gejala COVID-19 ringan, ambil ubat antiviral
Kevin O'Connor berkata gejala yang dialami presiden itu mempengaruhi sistem pernafasannya.